Acinetobacter baumannii is an opportunistic nosocomial pathogen and one of the six most important multidrug-resistant microorganisms in hospitals worldwide. This human pathogen is responsible for a vast array of infections, of which ventilator-associated pneumonia and bloodstream infections are the most common, and mortality rates can reach 35%. Community-acquired infections have also been reported, but few strains have been recovered from environmental sources and infection reservoirs external to the hospital have not been identified. The majority of A. baumannii infections are caused by two main population clones with worldwide distribution. Infection outbreaks are often associated with multidrug resistance, including the recent emergence of strains resistant to all available antibiotics. Nevertheless, A. baumannii virulence traits and pathogenic potential have mostly remained elusive. The recent expansion of A. baumannii sequenced genomes has permitted the development of large-array phylogenomic and phenotypic analyses, which can offer valuable insights into the evolution and adaptation of A. baumannii as a human pathogen. This review summarises these recent advances, with particular focus on A. baumannii evolutionary and genomic aspects, and proposes new avenues of research.
Introduction
Gram-negative coccobacilli classified as Acinetobacter baumannii are important Gram-negative opportunistic bacterial pathogens that are responsible for 2-10% of all Gramnegative hospital infections (Joly-Guillou, 2005) . Acinetobacter baumannii is classified by the Infectious Diseases Society of America as one of the six most important multidrug-resistant (MDR) microorganisms in hospitals worldwide (Talbot et al., 2006) The genus Acinetobacter has undergone many taxonomic changes over the years, and the species A. baumannii was not formally designated until 1986 (Bouvet & Grimont, 1986) . This makes earlier accounts of Acinetobacter infections in the scientific and medical literature difficult to interpret. Nevertheless, it seems apparent that infections caused by organisms now classified as A. baumannii first became a significant problem during the 1970s (Bergogne-B er ezin & Towner, 1996) . Since then, A. baumannii has gradually increased in importance as a pathogenic organism, mainly, but not exclusively, in the hospital environment. This increase in importance could, at least in part, be related to the fact that the patient mix in hospitals has changed since the early 1970s, with patients in hospitals now being much more vulnerable to A. baumannii infections because of their serious underlying conditions and advances in medicine that involve an increased use of highly selective antibiotics, indwelling lines and other invasive devices. Thus, while the aim of this mini-review is to summarise recent advances in knowledge concerning A. baumannii, with particular focus on the evolutionary and genomic aspects of A. baumannii pathogenicity, it should also be considered that the nature of the host (i.e. human patient) may also play a large part in the outcome of infections caused by A. baumannii.
infections and secondary meningitis (Bergogne-B er ezin & Towner, 1996; Roca et al., 2012; McConnell et al., 2013) . However, the most important infections, with the highest mortality rates, are ventilator-associated pneumonia and bloodstream infections (Dijkshoorn et al., 2007) . Infections are more common in patients suffering from an underlying disease or who have undergone major surgical procedures. Acinetobacter baumannii can easily enter the body through open wounds, intravascular catheters and mechanical ventilators. Infections caused by A. baumannii are associated particularly with extended periods of hospitalisation (Peleg et al., 2008) , the male gender and older age (Wisplinghoff et al., 1999) .
Less commonly, A. baumannii can also cause community-acquired infections, including pneumonia (accounting for 85% of reports of community infections caused by A. baumannii) and bacteraemia. Other possible community-acquired infections include skin, soft tissue and ocular infections, secondary meningitis and endocarditis (Chang et al., 2000; . These infections are more common in the male gender and are associated with old age, alcoholism, heavy smoking, diabetes mellitus, chronic obstructive pulmonary disease and renal disease. Community-acquired A. baumannii pneumonia is more serious than nosocomial pneumonia, is generally fulminant (death within 8 days of diagnosis) and rates of mortality can be as high as 60% (Falagas & Rafailidis, 2007) . Most reports of community-acquired pneumonia have occurred during the summer months in tropical and subtropical climates (Falagas & Rafailidis, 2007) .
A relatively recent phenomenon has been the association of A. baumannii with infections subsequent to injuries in conflict areas, for example Iraq and Afghanistan (Joly-Guillou, 2005), or following natural disasters such as the Marmara earthquake in Turkey (Centers for Disease Control & Prevention, 2004) . There is some evidence that the use of morphine, which might be expected following battlefield or crush injuries, may potentiate A. baumannii infections, perhaps as a result of its immunosuppressive effect (Breslow et al., 2011) . However, such outbreaks of A. baumannii infection may also be a reflection of the extreme pressure that hospital emergency units are under in such situations, leading to breakdowns in infection control precautions and consequent epidemic spread of A. baumannii (see below), rather than any direct causal association.
There is some debate over the severity of A. baumannii infections, with attributable mortality rates varying, on average, from 8% to 35%, according to strain and type of infection (Falagas & Rafailidis, 2007) . Accordingly, different A. baumannii strains could be endowed with different pathogenic potential, as suggested by two studies using the mouse model of pneumonia: an MDR strain isolated from the blood culture of a patient with nosocomial pneumonia showed 80% mortality to mice, in contrast to 13% mortality for a strain causing meningitis (Eveillard et al., 2010) , while a strain belonging to international clone 1 (see below) and a sporadic isolate were more virulent than a strain belonging to international clone 3 and the type strain . Differences in mortality may be attributable to the expression of specific virulence factors and determinants. For example, two strains with the same PFGE profile, where one was a mucoid isolate from cerebrospinal fluid and the other was a nonmucoid isolate from a ventriculo-peritoneal catheter, showed mortality rates of 48% and 19%, respectively, in a mouse model of pneumonia (Eveillard et al., 2010) .
Antibiotic resistance
The predominance of certain A. baumannii lineages has been related to the MDR phenotype of infecting strains (Diancourt et al., 2010) . However, it is currently not clear whether particular epidemic strains (see below) have acquired the MDR phenotype or whether the MDR phenotype is important for individual strains to become epidemic. Acinetobacter baumannii antimicrobial resistance has progressively increased since the 1970s, at which time the vast majority of strains were sensitive to commonly used antibiotics. By 2007, up to 70% of isolates in certain settings (depending on country, hospital, medical department and clinical sample) were MDR, including resistance to carbapenems, which were once considered to be the mainstay against MDR A. baumannii infections (Kempf & Rolain, 2012) . Not surprisingly, carbapenem resistance has been observed in isolates from military as well as civilian facilities (Keen et al., 2010; Mera et al., 2010) .
Currently, colistin seems to be the most reliably effective drug in vitro against MDR A. baumannii, but colistin use has been associated with a number of side effects and is not suitable for treating all types of infections (Falagas & Rafailidis, 2009 ). There are now also reports of colistin resistance worldwide (Cai et al., 2012) , resulting in the emergence of strains resistant to all known antibiotics in certain geographical areas (Al-Sweih et al., 2011) . Worryingly, resistance appears to be spreading to the community, with reports of carbapenem-resistant Acinetobacter spp. in cattle and other animals (Poirel et al., 2012; Seiffert et al., 2013) and in the Seine River in Paris, France (Girlich et al., 2010) .
Overall, A. baumannii has acquired resistance to a vast array of antimicrobials in recent decades. This capacity is partly dependent on the ability of this bacterium to acquire resistance genes, often by horizontal gene transfer (Adams et al., 2008) . Recent studies strongly suggest that acquisition of the MDR phenotype is a determinant factor for the success of A. baumannii as a nosocomial pathogen (Imperi et al., 2011) .
Individual antimicrobial resistance mechanisms in A. baumannii have been described in previous reviews (Peleg et al., 2008; Kempf & Rolain, 2012; Poirel et al., 2011; Cai et al., 2012; Evans et al., 2013) .
Epidemiology

Natural habitats
Contrary to other species of the Acinetobacter genus, which are frequently isolated from the soil, water and animals (Towner, 2009) , A. baumannii is found almost exclusively in the hospital environment, particularly in intensive care units (ICUs). Evidence is accumulating that a similar behaviour can be observed in veterinary medicine with infection and colonisation of seriously ill animals in veterinary clinics and ICUs (Zordan et al., 2011) . Although there are reports of occasional isolates of A. baumannii from nonhuman sources, such as animals, lice, vegetables, aquaculture and soils (Eveillard et al., 2013) , it remains to be assessed if these isolates, which are infrequent, are the result of contamination of the environment from the primary hospital reservoir or are indicative of an alternative natural reservoir of this species.
Population structure
The clinical relevance of A. baumannii has dramatically increased since the late 1980s, with the emergence and spread of three predominant clones ('international clonal lineages', ICLs) capable of causing hospital outbreaks worldwide, of which ICL1 and ICL2 are MDR. However, more than 400 MLST sequence types (STs) are currently listed in the A. baumannii MLST database (http://pubmlst. org/abaumannii/), and a recent analysis has evidenced the existence of at least six major ICLs distributed through continents worldwide (Karah et al., 2012) . These six ICLs include the three major outbreak clones identified originally and demonstrate the worrisome emergence of new epidemic clones. It has been suggested that this emerging population structure is the result of an initial low phylogenetic diversity of A. baumannii and subsequent rapid spread following a severe evolutionary bottleneck (Diancourt et al., 2010) .
Genome plasticity and evolution of virulence
Since the sequencing of the first A. baumannii genome in 2007 (Smith et al., 2007) , the field of Acinetobacter genomics has seen a rapid increase in the number of sequenced and annotated genomes. As at September 2013, 15 complete and 180 draft chromosomal A. baumannii genomes, 31 plasmid and six bacteriophage sequences are available on the NCBI database (http://www.ncbi.nlm.nih.gov), as well as the complete genome sequence of Acinetobacter baylyi, 57 draft sequences from other Acinetobacter species, four plasmid and five bacteriophage sequences.
This high number of available sequences has enabled comparative genomic analyses focused on resolving A. baumannii population structure and phylogenetic relationships and on elucidating clues concerning potential virulence factors and the origin of antimicrobial resistance determinants.
The A. baumannii core genome and pan-genome Comparative genomic approaches have identified a core set of species-specific (Adams et al., 2008; Peleg et al., 2008; Imperi et al., 2011; Farrugia et al., 2013) and genus-specific genes (Vallenet et al., 2008; Chan et al., 2012; Peleg et al., 2012; Zhan et al., 2012; Fondi et al., 2013) . The species core genome varies between 1455 and 2688 orthologous coding sequences (CDSs) depending on the number and identity of strains analysed (Adams et al., 2008; Imperi et al., 2011; Peleg et al., 2012; Farrugia et al., 2013) . Theoretical predictions of the core genome size of the current clinical strain population, obtained from development plots with an infinite number of genomes, point to a core genome of c. 2200 CDSs, corresponding to c. 60% of the average strain genome content (Imperi et al., 2011) . The functions coded by these genes are mostly related to metabolic and general cellular processes (65%), as well as hypothetical proteins (22%).
In contrast, the A. baumannii whole-genome repertoire (the 'pan-genome') is impressively large (over 8800 CDSs for 12 strains) and increases exponentially as new genomes become available (an open pan-genome), which highlights the importance of gene acquisition and loss events in the evolution and adaptation of this human pathogen. The greatest contribution to the species pan-genome is provided by genes that are not shared by all strains (the accessory genome), of which 25-46% of genes are unique to each strain (Adams et al., 2008; Imperi et al., 2011) . Compared to the core genome, the accessory genome is enriched in transport and transcription regulation functions (Adams et al., 2008; Imperi et al., 2011) . Strain-specific genes mainly encode hypothetical proteins (39%), transposases (36%) and insertion sequences (16%; Imperi et al., 2011) .
Acquisition of virulence determinants
Gene functions putatively associated with virulence are mostly found in the core genome of clinical strains, regardless of their grouping as clonal or sporadic isolates or their isolation date. The few exceptions are the genes belonging to the O-antigen biosynthetic cluster, which show very low conservation among genomes (Adams et al., 2008; Kenyon & Hall, 2013) . Notably, no single toxin, hydrolytic enzyme or adhesin was detected in the core genomes of ICL1 or ICL2 strains that could account for their clinical prevalence (Imperi et al., 2011) . In contrast, CDSs with functions related to adhesion and mobility, iron metabolism, quorum-sensing and two-component systems correspond to up to 8% of the core A. baumannii genome (Imperi et al., 2011) . This suggests that the acquisition of new virulence traits was likely not a predominant factor in the recent (post-1980s) nosocomial expansion of A. baumannii clones.
Thus, other explanations should be considered for the evolution of A. baumannii towards pathogenicity. One possibility is that the renowned ability of A. baumannii to adapt to the nosocomial environment and to resist adverse environmental challenges is the main factor for pathogenicity in this species. A second possibility is that the conserved set of A. baumannii virulence genes is differentially regulated according to strain. In fact, the A. baumannii genome contains 59 transcriptional regulators, which is twice the number found in A. baylyi ADP1 (Adams et al., 2008) ; however, no enrichment happened in the core genomes of ICL1 or ICL2 (Imperi et al., 2011) . Lastly, polymorphic differences in shared virulence genes (Peleg et al., 2012) or the combinatory effect of multiple genes (Imperi et al., 2011) may contribute to differences in virulence potential.
Acquisition of resistance determinants
Genes associated with resistance to antimicrobial drugs were found in both the species core and accessory genomes (Imperi et al., 2011) . In the accessory genome, antimicrobial resistance genes were found in alien islands and were often flanked by integrases, transposases or insertion sequences (Imperi et al., 2011) , suggesting their possible acquisition by horizontal gene transfer from other Acinetobacter strains or bacteria that colonise the same environment.
The genome of strain AYE, belonging to ICL1, encodes 52 genes putatively associated with resistance to antimicrobial drugs, of which 45 are encoded by an 86-kb resistance island (AbaR1). This genomic island is also present in other A. baumannii strains, but with a much reduced size. The presence of an extraordinary 22 ORFs coding for transposases and insertion sequences is probably responsible for the acquisition of resistance genes in the AYE AbaR1 island, the majority of which are orthologous to CDSs found in Pseudomonas spp. (44%), Salmonella spp. (34%) and Escherichia spp. (17%; Vallenet et al., 2008) .
The ICL2 strain ACICU also contains a homolog to AbaR1, but it is much smaller (seven antibiotic resistance coding genes). In this strain, drug resistance is more evenly distributed throughout the genome. For instance, CDSs for drug resistance functions are present in 14 of the 36 A. baumannii ACICU alien islands, but correspond on average to < 5% of the total CDSs of each island (Iacono et al., 2008) . The majority of these CDSs have orthologs in Pseudomonas spp. (22%) and Burkholderia spp. (18%).
Phylogenetic relationships
A phylogenetic analysis of 154 Acinetobacter strains belonging to clinically important species other than A. baumannii, based on the concatenation of six housekeeping genes (Diancourt et al., 2010) , has provided evidence for the monophyletic origin of A. baumannii, as well as for the monophyletic origin of the main Acinetobacter species of clinical importance (A. baumannii, A. pittii, A. nosocomialis). Together with the less clinically relevant A. calcoaceticus, these species comprise the A. calcoaceticus-baumannii (Acb) complex.
The monophyletic status of ICLs 1 and 2, the A. baumannii species, the Acb complex and the Acinetobacter genus have also been confirmed by phylogenomic analysis of 38 Acinetobacter species based on 127 core genes of the genus (Chan et al., 2012) and the phylogeny of 136 Acinetobacter genomes based on single-nucleotide polymorphism (SNP) analysis (Sahl et al., 2013) .
Acinetobacter core genome and pan-genome
The core genome of the genus Acinetobacter is much smaller than that of A. baumannii and has been estimated at 900-1300 CDSs for 37/38 Acinetobacter spp. (25-35% the average number of strain CDSs; Chan et al., 2012; Fondi et al., 2010) . This number rises to c. 2700 CDSs if only members of the Acb complex are considered (Peleg et al., 2012) . Thus, members of the Acb complex may have acquired (or retained) over 1400 CDSs that are absent from nonpathogenic Acinetobacter spp.
In contrast, as the core genome of A. baumannii has a comparable size to that of the Acb complex, it is plausible that, in large scale, the A. baumannii core genome was already represented in the Acb complex ancestral genome and that the evolution of A. baumannii was mostly due to the expansion of its accessory genome. In fact, when compared to A. calcoaceticus, A. baumannii appears to have acquired no more than 170 genes (Peleg et al., 2012) . As the majority of A. baumannii putative virulence-associated genes are coded in the species core genome and the species core genome seems to be very conserved in the Acb complex, then a comparative analysis of the genomes of Acb complex members could provide important clues concerning the evolution of A. baumannii towards pathogenicity. A recent comparative genomics study has demonstrated that very few potential virulence factors are exclusive to A. baumannii (Sahl et al., 2013) . One of these exceptions is a putative siderophore biosynthesis and uptake cluster, identified with accession numbers ACICU_01672-ACICU_01683 (Antunes et al., 2011b) .
Most A. baumannii putative virulence factors are conserved or exclusive to the important pathogenic members of the Acb complex (i.e. A. baumannii, A. pittii and A. nosocomialis). The tip adhesion gene csuE, which in A. baumannii is involved in pilus and biofilm formation, is conserved in all three of these species (Sahl et al., 2013) . Moreover, efflux pumps are almost exclusive to the Acb complex, with many of them showing orthology to efflux pumps of other bacterial pathogens, such as Pseudomonas spp. The acinetobactin siderophore cluster is conserved only in A. baumannii and A. pittii and may have been acquired by two independent horizontal gene transfer events, as these two species do not form a monophyletic clade, and in A. baumannii, the acinetobactin cluster is found in alien islands with a higher G+C content that are flanked by insertion sequences.
Interestingly, genes coding for a few virulence factors that have been implicated in A. baumannii infection (Roca et al., 2012) are also widely distributed in nonpathogenic Acinetobacter spp., such as those coding for the two-component BfmRS system, the outer membrane protein OmpA, the cell wall protein PBP 7/8 and phospholipases C and D (NCBI; http://www.ncbi.nlm.nih.gov/RefSeq/). This leaves questions as to whether they are active and what their roles may be in nonpathogenic Acinetobacter spp. Notably, several transcriptional regulators have been acquired by A. baumannii and by the Acb complex, a few of which are orthologous to transcriptional regulators of other human pathogens (Sahl et al., 2013) . Thus, they could be involved in the differential expression of these virulence factors, and their role in A. baumannii and Acb complex pathogenicity should not be underestimated.
Evolutionary theories for the emergence and success of A. baumannii
The genomic organisation of A. baumannii, involving a rather small core genome and a very large accessory genome (Imperi et al., 2011) , together with the low level of gene polymorphism in the species and the lack of intraspecies phylogenetic structure (Diancourt et al., 2010) , supports an evolutionary model involving two disjointed waves of expansion among the population of A. baumannii clinical isolates. The first followed a severe bottleneck in the pre-existing A. baumannii population that occurred at some undetermined time in the distant past, while a second wave is now developing through the rapid expansion of a limited number of multiresistant clones that have become highly problematic as nosocomial infectious agents (Diancourt et al., 2010) .
The evidence that the core genome of A. baumannii is in large part represented in the core genome of the Acb complex and that most A. baumannii virulence and resistance factors are conserved in the Acb complex or have orthologs in other nosocomial pathogens indicates that A. baumannii may have diverged from the Acb complex at some stage during its evolutionary history. The recent event that limited the genomic diversity of the A. baumannii population might have been directly or indirectly connected to the introduction of intensive antibiotic therapy (post-1950s) . In that scenario, the recent rapid expansion of very homogenous clonal lineages (post-1980s), whose main difference from nonclonal A. baumannii appears to be their antimicrobial resistance, may have resulted from the horizontal acquisition of resistance genes from other nosocomial pathogens.
An alternative hypothesis is that the current breadth of knowledge on nosocomial A. baumannii strains does not represent the true diversity of the species. Strains recovered from cases of community-acquired infection show different clinical, epidemiological and phenotypic characteristics .
Recently, the genome sequence of a strain responsible for a bacteremic community infection has become available (Farrugia et al., 2013) . Strain D1279779 did not belong to any of the two major ICLs, was antibiotic susceptible and, accordingly, lacked many of the A. baumannii resistance determinants, including the AbaR resistance island. Possibly for this reason, its genome is c. 250 kb smaller and 300 CDSs shorter than the average A. baumannii genome. Nevertheless, the D1279779 genome encodes many of the A. baumannii virulence-associated factors (e.g. acinetobactin, a capsule, type I and type IV pili, phospholipases C and D). These facts have led to the suggestion that this strain might be a representative of an 'environmental or preantibiotic era' lineage (Farrugia et al., 2013) .
In addition, both D1279779 and the clinical strain ATCC 17978 (isolated in 1951 and antibiotic susceptible) use a greater breadth of carbon and nitrogen sources compared to strains belonging to the ICLs. 'Environmental' A. baumannii isolates recovered from soil, water and food samples also show extensive genetic diversity compared with clinical A. baumannii isolates (P. Visca, unpublished results). Thus, ATCC 17978, D1279779 and other nonclinical, nonclonal A. baumannii isolates might represent a wider diversity of the A. baumannii population, which did not undergo selection by antimicrobials and consequently did not experience an evolutionary bottleneck. The answer to this question will depend on widening comparative genomic studies on a larger repertoire of 'nonclinical' A. baumannii isolates.
Multifactorial and combinatorial virulence
Virulence factors
In recent years, combinatorial approaches involving genomic, phenotypic and infection model analyses have helped in the identification of virulence factors important for A. baumannii pathogenicity. So far, outer membrane proteins, hydrolytic enzymes and multifactorial phenotypes have been confirmed as being implicated in A. baumannii pathogenicity. The main outer membrane protein OmpA (Choi et al., 2005) is involved in epithelial cell invasion and apoptosis. Phospholipases C and D are responsible for survival in human serum and epithelial cell invasion (Camarena et al., 2010; Jacobs et al., 2010) . The siderophore acinetobactin (Gaddy et al., 2012) , the cell capsule (Russo et al., 2010) and a penicillin-binding protein 7/8 (Russo et al., 2009) are important for survival in human serum. Growth in serum has also been shown to significantly upregulate iron acquisition systems, genes associated with epithelial cell adherence and DNA uptake, as well as numerous putative antibiotic efflux pumps, leading to increased antibiotic tolerance (Jacobs et al., 2012) . In addition, lipopolysaccharide (LPS) is an important cell envelope component, which might play an important role in causing septic shock once A. baumannii enters the bloodstream. To date, LPS has received relatively little attention in studies of A. baumannii virulence, but it has become evident that most Acinetobacter LPS molecules contain an O-polysaccharide chain (O-antigen), which has been reported to influence the pathogenic potential of other Gram-negative bacteria (Pantophlet, 2008) . There also appears to be a general O-glycosylation system that appears to be important for biofilm formation and virulence, and the capsular polysaccharide, which is essential for resistance to complement killing (Iwashkiw et al., 2012) . Mutations in the initiating glycosyltransferase have been shown to prevent the synthesis of both glycoproteins and capsule, resulting in abnormal biofilm structures and attenuated virulence in mice (Lees-Miller et al., 2013) .
The lipid A part of the LPS synthesised by A. baumannii likely also plays a similar role in septic shock as that documented for the endotoxin of Enterobacteriaceae. Its main pathogenic role is to induce a strong inflammatory response in systemic infection, but to date, there have been no published studies in strains of A. baumannii that have specifically addressed this point. Intriguingly, whole cells of clinical A. baumannii isolates were found to induce a weaker response, expressed as pro-inflammatory cytokine production by macrophages and epithelial cells, than isolates belonging to the relatively nonpathogenic species Acinetobacter junii, suggesting that A. baumannii may survive and persist in the airways of patients and cause disease at least in part by eluding the induction of the host's inflammatory response (de Breij et al., 2010) . This is in apparent contrast with a recent study showing that LPS-mediated activation of TLR4 was crucial for A. baumannii pathogenicity in a murine model of systemic infection and that TLR4 activation occurred as a consequence of LPS shedding . Thus, it appears that released (rather than cell-associated) LPS is relevant to A. baumannii pathogenicity and that more virulent A. baumannii strains shed more LPS during growth than less virulent strains, resulting in enhanced TLR4 activation and host damage .
Moreover, several other factors contribute to biofilm formation and help sustain cell survival on biotic and abiotic surfaces, such as the Csu pili (Tomaras et al., 2003) , the two-component system BfmRS (Tomaras et al., 2008) , a quorum-sensing system (Niu et al., 2008) , the surface protein Bap (Fattahian et al., 2011) , the OmpA protein, the exopolysaccharide poly-b-1,6-N-acetylglucosamine (PNAG; Bentancor et al., 2012b) and the autotransporter Ata (Bentancor et al., 2012a) . Additional information on A. baumannii virulence factors and mechanisms of host-pathogen interaction can be found in previous reviews (Mortensen & Skaar, 2012; McConnell et al., 2013; Roca et al., 2012) .
Nonetheless, no single toxin, hydrolytic enzyme or surface protein has been identified that can unequivocally account for the increased pathogenicity of the ICLs; thus, the reason for the predominance of ICLs 1 and 2 in outbreaks of A. baumannii infection is still unclear. The ICLs do not show increased pathogenicity in animal infection models. An ICL1 (AYE), an ICL2 (ACICU) and a non-ICL (ATCC 17978) strain showed comparable lethality in an insect infection model (Antunes et al., 2011a) , and a similar result was obtained for a wider collection of strains, including ICL1 and ICL2 clones and the recent emerging genotypes ST25 and ST78 (Giannouli et al., 2013) . An ICL1, an ICL2 and a non-ICL strain also showed comparable mortality in a neutropenic mouse infection model . Moreover, an ICL1 strain (AYE) was less virulent than a non-ICL strain in a mouse model of pneumonia (Eveillard et al., 2010) .
Thus, in summary, no individual factor has been identified that can account for the predominance of the ICLs. ICL2 seems to have become more widely prevalent than ICL1, but their dissemination and colonisation patterns among patients during outbreaks seem to be broadly similar. Each ICL appears able to express a multiplicity of virulence factors and to do so in different combinations. Indeed, ICL1 and ICL2 might have different pathogenic strategies: several studies have reported that ICL1 isolates show higher motility (Antunes et al., 2011a; Eijkelkamp et al., 2011) and higher resistance to desiccation (Antunes et al., 2011a; Giannouli et al., 2013) than ICL2 and non-ICL isolates. Conversely, ICL2 isolates show higher adherence and biofilm formation than ICL1 and non-ICL isolates (Lee et al., 2006; de Breij et al., 2010; Antunes et al., 2011a; Giannouli et al., 2013) , as well as higher proteolytic activity (Antunes et al., 2011a) .
In addition, in agreement with the apparent conservation of virulence-associated genes in the core genome of the species, a nonclinical strain (SDF) showed levels of production of exoenzymes with haemolytic, proteolytic and phospholipase C activities comparable to those of clinical strains, as well as high levels of biofilm formation and an ability to survive in human serum (Antunes et al., 2011a) .
Furthermore, members of the genus Acinetobacter are able to express virulence-related phenotypes regardless of their status as clinical or nonclinical isolates. Although less toxic and infective in an epithelial cell model, nonclinical Acinetobacter spp. showed haemolytic activity comparable to A. baumannii and were equally resistance to macrophage phagocytosis (Tayabali et al., 2012) . Moreover, A. baumannii was less adherent than the less clinically relevant species of the Acb complex and showed similar survival in a murine thigh infection model (Peleg et al., 2012) .
Taken together, these results support a multifactorial and combinatorial strategy of A. baumannii virulence, a scenario that is reminiscent of P. aeruginosa virulence (Lee et al., 2006) . This hypothesis is supported by the systematic failure of studies on A. baumannii virulence to identify a particular virulence factor unequivocally responsible for the clinical success of A. baumannii, including the inability to identify bona fide virulence genes by a transposon inactivation approach (Smith et al., 2007) . This perspective highlights the strong adaptive potential of this species and could be the result of the adaptation to different human body sites or different pathogenic strategies (Sahl et al., 2011) , as is the case for E. coli, Bacillus spp., Legionella spp. and other pathogenic bacteria (Pallen & Wren, 2007) .
In addition, all clinical A. baumannii isolates have the ability to grow in iron-depleted media, survive fever-associated temperatures and are more resistant to desiccation, antimicrobials (Antunes et al., 2011a; Giannouli et al., 2013) and heavy metals (P. Visca, unpublished results). These data further suggest that the emergence of the ICLs is probably not directly connected to the acquisition of individual virulence factors, but is the result of their resistance phenotype, a hypothesis that is also supported by genomic comparative analysis (Imperi et al., 2011; Sahl et al., 2013) .
Regulation of virulence
Combinatorial approaches to the study of A. baumannii virulence have revealed that: (1) ICL strains do not have unique virulence factor expression that is absent from non-ICL clinical strains; thus, at least at present, their clinical predominance cannot be reasonably ascribed to increased virulence potential; (2) clinical strains do not have a set of unique virulence factors that are absent from nonclinical strains; (3) A. baumannii does not encode unique virulence factors absent from the genomes of other Acinetobacter spp.
Three hypotheses can be considered:
(1) Individual virulence factors may not be important for A. baumannii virulence in a human host, despite the fact that several of them have been found to be important in animal infection models (McConnell et al., 2013) .
(2) Alternatively, the same virulence factor might play a different role in different habitats. For instance, the high level of biofilm formation found in ICL2 strains and the nonclinical strain SDF (Antunes et al., 2011a) could reflect multiple functions of biofilm in A. baumannii, a strategy that is not uncommon in species with high habitat plasticity (Jensen et al., 2003) .
(3) Lastly, the expression of virulence-associated genes could be under different regulation in pathogenic and nonpathogenic species; similar evolutionary profiles are widespread in other bacterial pathogens that have multiple habitats (Pallen & Wren, 2007) . Comparative genomic analyses have identified a high percentage of transcription factor regulators in the core genome and pan-genome of A. baumannii and pathogenic Acinetobacter spp. (Imperi et al., 2011; Sahl et al., 2013) . However, the role of gene regulators in controlling A. baumannii virulence remains largely unknown. A recent study has reported the identification of a homolog of H-NS, a global negative regulator of virulence in many Gram-negative bacteria, in the genome of clinical strain ATCC 17978 . In this strain, inactivation of the H-NS gene resulted in increased expression of type I pili, the type IV secretion system, the Ata autotransporter and the AbaR resistance island, which had effects on the hydrophobicity, adherence and motility of the strain. In E. coli and other bacteria, H-NS is regulated by environmental cues, such as temperature, pH and osmolarity (Fang & Rimsky, 2008) . It remains to be assessed what factors determine the activation of H-NS in A. baumannii.
Environmental strains
If the expression of particular virulence factors in A. baumannii is dependent on strain habitat and evolution, then it is important to investigate the diversity of the nonclinical A. baumannii population.
The only nonclinical A. baumannii strain that has been well characterised to date, strain SDF, was isolated from the gut of a body louse from a homeless person (La Scola & Raoult, 2004) . SDF shows some characteristics that could be linked to its particular adaptation for survival in this host, namely extensive biofilm production, serum resistance and haemolytic activity, as well as the genomic capacity for haem uptake (Antunes et al., 2011b) . SDF could be an example of specialisation to a particular niche or host (Lawrence, 2005) . Its genome is smaller than those of clinical strains and contains numerous insertion and prophage sequences, which could indicate a reductive evolution by pseudogenisation and gene loss, and SDF is less resistant to high temperatures, iron starvation and desiccation. Curiously, SDF is prototrophic (Vallenet et al., 2008) and still shares some of the virulence determinants present in clinical strains (Antunes et al., 2011a) , suggesting that these determinants have a different function in this strain or are not expressed, perhaps therefore providing an example of a continuing reductive evolutionary process (Pallen & Wren, 2007) .
Recently, the genome of a second Acinetobacter strain isolated from an haematophage gut, Acinetobacter sp. HA, has been sequenced (Malhotra et al., 2012) . The genome of this strain is also smaller than the average clinical A. baumannii genome (3.1 Mb vs. c. 3.9 Mb) and lacks many of the putative A. baumannii virulence genes. The species classification of this strain is still uncertain, but its closest neighbours are A. lwoffii and A. baumannii (Malhotra et al., 2012) .
Concluding remarks
The development of large-scale comparative genomic and phenotypic approaches has provided important tools for the study of the evolution of A. baumannii as a global pathogen. The virulence potential of A. baumannii seems to be a characteristic of this species, as well as other pathogenic members of the Acb complex. The available evidence suggests that A. baumannii virulence is probably multifactorial and combinatorial, with the epidemic ICLs 1 and 2 possibly using different combinations of virulence and resistance determinants to optimise adaptability to the human host. However, the success of A. baumannii as a human pathogen seems to be intimately linked with the acquisition of antibiotic resistance genes via horizontal gene transfer. It seems that A. baumannii is endowed with the ability to adapt to different habitats, but that a reduction in its genetic diversity, possibly following the introduction of antibiotic therapy in the 1950s, led to the evolution and spread of a few highly homogenous clones that were specifically adapted to the nosocomial environment. Nevertheless, several questions and technical shortcomings need to be addressed before a complete picture of the evolution of this important human pathogen can be obtained.
Firstly, the presence of a high number of hypothetical proteins (c. 22%) in the species core genome and pan-genome may have obscured genes important for A. baumannii pathogenicity, such as toxins, hydrolytic enzymes or cell surface components, that could explain the prevalence of the ICLs.
Secondly, the genomes of pathogenic members of the Acb complex and A. baumannii are enriched with transcription factor regulators. Their role in the evolution of A. baumannii as an important human pathogen, particularly in the regulation of virulence and the success and adaptation of the international clones, remains to be addressed.
Thirdly, most current studies of A. baumannii pathogenicity have been limited to an analysis of chromosome-encoded sequences, although plasmid and phageencoded CDSs also make an important contribution to the pan-genome of A. baumannii (Fondi et al., 2010; Di Nocera et al., 2011) . For example, 8 of 85 AB1 phage CDSs show homology in A. baumannii genomes (Li et al., 2012) , indicating recombination between the chromosomal and phage genomes. In addition, a high degree of sequence similarity was found between plasmid-and chromosome-encoded genes (over 40% of CDSs at 50% sequence identity) for 29 Acinetobacter plasmids and 329 plasmid-encoded CDSs (Fondi et al., 2010) , thus indicating that considerable recombination occurs between Acinetobacter plasmids and A. baumannii chromosomal sequences.
Finally, most studies have focused on the comparative genomics of clinical strains, but it is not known whether the diversity found among clinical A. baumannii strains is representative of the whole A. baumannii population diversity, particularly considering the fact that A. baumannii can be isolated, albeit with low (< 10%) recovery rates, from soil, water, vegetable and animal sources (Eveillard et al., 2013) . Thus, further analysis of the phylogenetic diversity of nonclinical A. baumannii isolates should help to gain a more complete understanding of the processes leading to the relatively recent evolution of this species as a global pathogen.
